Phenotypic detection of extended-spectrum beta-lactamase produced by Klebsiella pneumoniae isolated from different clinical samples from intensive care unit, Khamis Military Hospital, Abha, Kingdom of Saudi Arabia
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20233070Keywords:
Klebsiella, Multi-drug-resitance, Lactamase, CarpabenemaseAbstract
Background: Klebsiella pneumoniae is an opportunistic pathogen that is one of the commonest causes of infection in intensive care units. K. pneumoniae infection have contributed considerably to morbidity and mortality in patients with chronic illnesses. The coexistence of virulence factors and the genetic determinant of antibiotic resistance complicates treatment outcomes. The emergence of pathogenic multi-drug resistant K. pneumoniae poses a great threat to the healthcare system. Thus, the aim of this study was to isolate and to phenotypically detect the extended-spectrum beta-lactamase produced by K. pneumoniae that are isolated from different clinical samples from ICU in Khamis Military Hospital.
Methods: A retrospective observational study was conducted at Khamis Military Hospital from December 2021 to April 2022. Clinical samples collected within the ICU underwent microbiological identification phase to confirm the presence of K. pneumoniae. This was followed by antibiotic susceptibility testing to various antimicrobial agents to detect the production of carbapenemases (KPC, NDM-1, OXA-48) and extended spectrum beta lactamase (ESBL). The collected data were subjected to statistical analysis using appropriate tools. Descriptive statistics were used to summarize the demographic and clinical characteristics of the patient population from whom the samples were obtained.
Results: A total of 114 isolates of K. pneumoniae were identified from different clinical samples of ICU patients. The percentage of ESBL production constituted 28.94% (33 isolates). Regarding the distribution of carbapenemases production, 43 isolates (37.7%) had the KPC and NDM carbapenemases, while 34 isolates (29.8%) had the OXA-48 carbapenemases.
Conclusions: The high prevalence of K. pneumoniae represents a threat to ICU patients, thus, this issue should be treated with urgent attention. Our data informs the need for regular surveillance of antibiotic resistance in pathogenic bacteria in clinical settings for meaningful control of emergence and spreading of multi-drug-resistant K. pneumoniae.
References
Calfee DP. Recent advances in the understanding and management of Klebsiella pneumoniae. F1000 Res. 2017;6:1760.
Czekaj T, Ciszewski M. Klebsiella pneumoniae NDM-new emerging superbacteria. Med Rodz. 2015;1:12-27.
Kotb S, Lyman M, Ismail G, Fattah M, Girgis SA, Etman A, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using national healthcare-associated infections surveillance data, 2011–2017. Antimicrob Resist Infect Control. 2020;9:2.
Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18.
Reyes J, Aguilar AC, Caicedo A. Carbapenem-resistant Klebsiella pneumoniae: microbiology key points for clinical practice. Int J Gen Med. 2019;12:437-46.
Molton JS, Tambyah PA, Ang BSP, Ling ML, Fisher DA. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis. 2013;56(9):1310-8.
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597-602.
Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933-51.
Rawat D, Nair D. Extended-spectrum ß-lactamases in gram negative bacteria. J Glob Infect Dis. 2010;2(3):263.
Sharma M. Prevalence and antibiogram of extended spectrum β-lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagnostic Res. 2013;7(10):2173-7.
Bobenchik AM, Hindler JA, Giltner CL, Saeki S, Humphries RM. Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp. Carroll KC, ed. J Clin Microbiol. 2014;52(2):392-7.
Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657-86.
Cheng HY, Chen YS, Wu CY, Chang HY, Lai YC, Peng HL. RmpA Regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43. J Bacteriol. 2010;192(12):3144-58.
Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20(7):1170-5.
Cienfuegos-Gallet AV, Ríos AM, Viana P, Brinez F, Castro C, Villamil G, et al. Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study. BMC Infect Dis. 2019;19(1):830.
Vading M, Nauclér P, Kalin M, Giske CG. Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality. PLoS One. 2018;13(4):0195258.
ElMahallawy HA, Zafer MM, Amin MA, Ragab MM, Al-Agamy MH. Spread of carbapenem resistant Enterobacteriaceae at tertiary care cancer hospital in Egypt. Infect Dis (Auckl). 2018;50(7):560-4.
Ahmad S, Al-Juaid NF, Alenzi FQ, Mattar EH, Bakheet OES. Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia. J Coll Physicians Surg Pak. 2009;19(4):264-5.
Salabi A, Walsh TR, Chouchani C. Extended spectrum β-lactamases, carbapenemases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteria. Crit Rev Microbiol. 2013;39(2):113-22.
